Immunotherapy
Automated, closed, integrated process development and manufacturing for CAR T and NK cells
Manufacturing Sophisticated Solutions in Immunotherapy
OmniaBio is uniquely equipped to pioneer sophisticated solutions to complex and nuanced manufacturing challenges for cellular immunotherapies. We leverage both in-house expertise and key partnerships to solve technical bottlenecks. With our integrated platforms tailored to improve productivity and overcome the hurdles in immune cell proliferation and function, we are positioned to be your partner in delivering both autologous and allogeneic engineered cell therapies.
Immunotherapy Offerings
- Closed, reproducible, consistent and GMP-ready processes
- An integrated team of process development experts and MSAT scientists, enabling seamless technology transfer
- A modular approach that allows for technology-agnostic, custom solutions
- Qualified assays for immunotherapies to quantify potency, purity, identity and viability
- Custom assay development
Services for Your Project Phase
Process
Development
Experts in optimization to ensure reliable scale-up to produce cell and gene therapies.
GMP
Manufacturing
Our state-of-the-art facility is equipped with the tools and flexibility to manufacture your product at a commercial scale.
Analytical
Development
Providing a robust suite of analytical capabilities that are integrated through your product’s lifecycle to support the development process.
Regulatory
Support
With in-depth knowledge, we can guide you through the regulatory landscape to approval.
